Published in Law and Health Weekly, June 10th, 2006
This trend article about Cardiff University is an immediate alert from LawRx to identify developing directions of research.
"MT1-MMP, otherwise known as MMP14 is a proteolytic enzyme known to be involved in degradating extracellular matrix and assist progression of cancer invasion and progression. We investigated the impact of targeting the expression of MT1-MMP in breast cancer and its clinical relevance," wrote W.G....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly